Believe it or not, the country spends a hundred dollars on life-saving medicine, and the drugstore sells almost 4,000 dollars.
It's not a story, it's a real story, it's a story, it's a story, it's about anyone who needs a drug, and it's about something, and it's about to shake up, and it's life-saving
The timeline is clear. In march of this year, official pricing papers were distributed to pharmacies, involving a holocaust and holt health-care point pharmacies, and selling a drop-down-rate-of-the-a-art aphrodisiac!
Most of the people who bought this drug were long-term slabs, which were supposed to save a lot of money from a collection policy!
Many people don’t know why the pharmacies dared to do this, but they had accumulated a large amount of pre-priced high-priced stocks ahead of time in order to sell their business losses to uninformed ordinary consumers, policy dividends, and cut-off of hard-born life。
Today’s life in real pharmacies is not much better, with a cumulative industry of $296. 1. 1 billion in 2025, a decline of 2. 2 percentage points in comparison to the previous year, and a number of small and medium-sized pharmacies, as policy adjustments are simply disallowing eligibility for health-care coverage。
Moreover, as of 2024, there were nearly 390,000 drug chains in the country, the chain rate had dropped to around 57 per cent, and single-body pharmacies were still low. The management of such shops was already loose, and many owners had their own first reaction, and it was not possible to control whether the patient had spent money
To put it in the context of the unusual logic behind the pharmacies, many of whom, in the belief that the pharmacies will make a lot of money to sell drugs, are now placing the prices of commonly used life-saving drugs at a very low level, and many pharmacies are selling them at no cost, or even at no cost, by hoarding old drugs at high prices to make up for the shortfall, which is a good cost transfer
This behaviour also exposes the general problem of the industry, which now has about double the total turnover of assets in the chain of pharmacies on the market. There is already considerable room for improvement in the efficiency of the operation of assets. There are many small pharmacies whose inventory management is even more chaotic, and when policy is adjusted, the first thought is the slaughter of customers, and the challenges ahead are enormous!
This is not an isolated case, it's a microcosm of a concentration of trade tensions, both under the real pressure of pharmacies and inaccuracies, digging invisible pits for ordinary consumers.
I think of a few details, and now many pharmacies are promoting fee-paying membership. Do you understand that the higher the membership fees, the higher the discounts on medicines, the 20 percentage points difference, isn't that a disguised selection of consumers and the fact that ordinary people are the worst!
There's a comment from the netizens that life-saving drugs are sold at over 30 times the price, that supervision, that support scrutiny, that these pharmacies should be heavily punished, that they can save lives
It's not like we're just a regular consumer, you can go to the health department's official website and check out the public price of the drugs, ask two or three pharmacies for the price, and find out how much money we can get and how much money we can get!
Transparency in drug prices is now a major trend, there is a professional pharmaceutical information platform that can find different sources of drug prices, consumers can avoid most of the poor information traps with one eye open, and pharmacies can be forced to regulate pricing, and long-term businesses are never made by predators
In the future, as the integration becomes deeper online, the physical pharmacies have long gone beyond selling medicines, and many community pharmacies have begun to put in place rapid testing equipment to produce multi-indicatorial health assessment results in one minute, slowly transforming into community health management hubs
Of course, there are many new problems in the transition process. As long as regulation is filled in time and consumer awareness of rights slowly emerges, we ordinary people will be able to get more and more of the price of drugs, and no longer have to worry about the high price of life-saving drugs。
